Literature DB >> 12825484

Congenital mixed malignant germ cell tumor involving cerebrum and orbit.

Jui-Chi Lee1, Shih-Ming Jung, An-Shine Chao, Chuen Hsueh.   

Abstract

Congenital intracranial tumors are rare and only account for 0.5 to 1.5% of all pediatric brain tumors. Teratoma is the most frequently encountered intracranial tumor at birth. Cephalomegaly and hydrocephalus are the usual clinical presentations. Advances in imaging techniques have improved diagnostic accuracy in congenital brain tumors. But the prognosis of a massive intracranial teratoma is always dismal. We report a congenital mixed malignant germ cell tumor in a male fetus at 27 weeks of gestation, with massive involvement of cerebrum and orbit. According to histological and immunohistochemical studies, the tumor was made up of predominantly immature teratoma combined with a yolk sac tumor. To our knowledge, such a combination has not been well documented in the literature.

Entities:  

Mesh:

Year:  2003        PMID: 12825484     DOI: 10.1515/JPM.2003.036

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  4 in total

1.  A report of nine newborns with congenital brain tumours.

Authors:  Henrik Carstensen; Marianne Juhler; Lars Bøgeskov; Henning Laursen
Journal:  Childs Nerv Syst       Date:  2006-06-28       Impact factor: 1.475

2.  A mature cystic teratoma in pineal region mimicking parietal encephalocele in a newborn.

Authors:  M Kemali Baykaner; Ertan Ergun; Berker Cemil; Pelin Bayik; Hakan Emmez
Journal:  Childs Nerv Syst       Date:  2006-10-20       Impact factor: 1.475

3.  Primary orbital yolk sac tumour in a 14-year-old girl.

Authors:  Zubair Ahmad; Amna Khurshid; Asim Qureshi
Journal:  BMJ Case Rep       Date:  2009-11-18

4.  Congenital cerebellar mixed germ cell tumor presenting with hemorrhage in a newborn.

Authors:  Sung Mok Kim; Ji Hye Kim; So-Young Yoo; Won Soon Park; Yun-Sil Jang; Hyung-Jin Shin; Yeon-Lim Suh
Journal:  Korean J Radiol       Date:  2008-07       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.